Sacubitril And Valsartan Tablet
Product Images NDC 70710-1273

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sacubitril And Valsartan (NDC 70710-1273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 01)

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 02)

This information provides the geometric mean ratio and 90% confidence intervals for the coadministered drugs listed, highlighting changes relative to the reference drug. The drugs included are Furosemide, Warfarin, Digoxin, Carvedilol, Levonorgestrel, Ethinyl estradiol, Amlodipine, HCTZ, Metformin, Atorvastatin, and Sildenafil.*

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 03)

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 04)

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 05)

FDA Label Image

Fig 5 (5ac80900 51d2 40f9 B897 Df34ace38cfe 06)

This dataset appears to provide information on the number of events per 100 patients for heart failure hospitalization and cardiovascular death in a study involving sacubitril and valsartan compared to valsartan alone. The graph shows the time in days since randomization and the number of patients at risk at different time intervals. The data suggests that the combination of sacubitril and valsartan may have benefits for heart failure patients compared to valsartan alone.*

FDA Label Image

Fig 6 (5ac80900 51d2 40f9 B897 Df34ace38cfe 07)

FDA Label Image

Fig 7 (5ac80900 51d2 40f9 B897 Df34ace38cfe 08)

This appears to be a comparison study named PARAGON-HF between sacubitril and valsartan versus enalapril, as well as sacubitril and valsartan versus valsartan. The hazard ratio is being calculated with left ventricular ejection fraction at screening expressed in percentage. It seems to be a clinical trial related to heart failure management.*

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 09)

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 10)

This text seems to describe a dosage for a medication called sacubitril and valsartan. It indicates the tablet strength, the number of tablets per container, and possibly some information on dosing instructions. The medication is available in a 49 mg/51 mg strength and comes in a container with 60 tablets. Additionally, there seems to be a reference to a particular temperature range for storage.*

FDA Label Image

Image (5ac80900 51d2 40f9 B897 Df34ace38cfe 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.